Note s4
121 subscribers
329 photos
69 files
77 links
Download Telegram
๐Ÿ”นุงู„ุฃุฑู‚ุงู… ุงู„ู„ูŠ ุชุฎุต ุฌุงุจุชุฑ ุงู„ู…ูŠู„ู†ูƒ ูˆุงู„ุฏุฑุงูŠู†ูƒ

๐Ÿ”ธCoarse / size large 20-mesh

๐Ÿ”ธintermediate / 20-200mesh
(74-840) micron

๐Ÿ”ธFine for particles /smaller than 200 - mesh

๐Ÿ”ธHammer mill used for
granulation (16-mesh) ,miling crystalline (120-mesh)

๐Ÿ”ธCutter mill

Horizontal rotor with 2 to 12 knives
Turning from 200 to 900

๐Ÿ”ธRoller mile / two to five smooth roller

Two cylindrical rolls mounted horizontally

๐Ÿ”ธHammer Miill / using high speed rotor(10.000 rpm )
Size reduction of 20-40

๐Ÿ”ธFluid energy mill
At pressure of 100 to 150 pound per square inch (psi)

๐Ÿ”ธMoisture content/more than 5%water hinder comminution and produce a sticky mass
๐Ÿ”ธGreater than 50% / slurry or
fluid suspension

๐Ÿ”นุฌุงุจุชุฑ ุงู„ุฏุฑุงูŠู†ูƒ

๐Ÿ”บMoving bed system / rotating slowly at ( 0.1 to 1.0 ) rpm

๐Ÿ”บFlash dryer / velocity 3000-6000 at temperature / 300-1300 air stream

๐Ÿ”บPre - freezing below or at -20 C
#drying
#milling
โ‡๏ธRapid acting insulin (lispro, aspart , glulisine)โžก๏ธ IV +SC .

โ‡๏ธshort acting (regular )โžก๏ธ IV โžก๏ธ in emergency cases

ุจุงู‚ูŠ ุฃู†ูˆุงุน ุงู„ุงู†ุณูˆู„ูŠู† ู…ูŠุตูŠุฑ ู†ู†ุทูŠู‡ู† IVโŒ
ู†ู†ุทูŠู‡ู† ูู‚ุท SC(ุงู„ูŠ ู‡ู†ู‡ intermediate +long)

#diabetic chapter

#
ุจู„ู†ุณุจู‡ ูƒ ู…ู„ุฎุต ู„ู„ู€ adrenal
ุงู„ุทุจู‚ู‡ ุงู„ุฎุงุฑุฌูŠู‡ G (meniral) ุชูุฑุฒ ุงู„ุฏูˆุณุชูŠุฑูˆู†
ุงู„ู…ุชูˆุณุทู‡ F(gluco) ุชูุฑุฒ ูƒูˆุฑุชุฒูˆู„  
ุงู„ุทุจู‚ู‡ ุงู„ุฏุงุฎู„ูŠู‡ R (androgen) ุชูุฑุฒ ุงู†ุฏุฑูˆุฌูŠู†


Coactiviter (on)
Corepressor (off)

ุจู„ู€ gluco ู…ู† ุชู‚ู„ ุงู„ู…ู†ุงุนู‡ ูˆุชู‚ู„ ูˆูŠุงู‡ุง ุจุงู‚ูŠ ุงู„ุฎู„ุงูŠุง ุชุฒูŠุฏ ุงู„ู‡ูŠู…ูˆฺฏู„ูˆุจูŠู† ูˆ ุงู„ุจู„ุงุชู„ูŠุช ูˆ ุงู„ุงุฑุซุฑูˆุณุงูŠุช ูˆ ู„ูŠูƒูˆ ุณุงูŠุช ูˆ ูŠู‚ู„ ุงู„ู‡ุณุชุงู…ูŠู†

ุจู„ู€ mineral ูŠุณูŠุทุฑ ุน ุญุงู„ู‡ ุงู„ fluid ูˆ ูŠุญุณู† ุงุนุงุฏุฉ ุงู…ุชุตุงุต ุงู„ุงูŠูˆู†ุงุช ูˆ ุฎุงุตู‡ ุงู„ุตูˆุฏูŠูˆู… ูˆ ุงู„ุจูˆุชุงุณูŠูˆู…
ูู€ ูˆุธูŠูุฉ ุงู„ู€ aldosteron ูŠุญุณู† ุงุนุงุฏู‡ ุงู…ุชุตุงุต ุงู„ุตูˆุฏูŠูˆู… ูˆุงู„ู…ุงุก ูˆุงู„ุจูŠูƒุงุฑุจูˆู†ุงุช ูˆ ูŠู‚ู„ู„ ุงุนุงุฏุฉ ุงู…ุชุตุงุต ุงู„ุจูˆุชุงุณูŠูˆู…
ูˆุงุฐุง ุตุนุฏ ูŠุณุจุจ ุญู…ูˆุถู‡ ูˆ ู‡ุงูŠุจูˆูƒุงู„ูŠู…ูŠุง ูˆุงุญุชุจุงุณ ุตูˆุฏูŠูˆู… ูˆ ู…ุงุก
ูˆุงุนุงู„ุฌู‡ ุจู„ู€ spironolactone
spironolactone
#adrenal
ุนู„ุงุฌุงุช ุงู„ corticosteroids
ูŠุนุงู„ุฌ ุงู„ู€
1-Addison
ุจู„ู‡ุงูŠุฏุฑูˆูƒูˆุฑุชูŠุฒูˆู† ูˆ ู†ู†ุทูŠ ูˆูŠุงู‡ ูู„ูˆุฏุฑูˆูƒูˆุฑุชูŠุฒูˆู†

2- ุนู„ุงุฌ ุจุฏูŠู„ ู„ู„ู€ ู†ู‚ุตุงู† ุจู„ู€ CRH ูˆ ุงู„ู€ ACTH
ู†ู†ุทูŠ ู‡ุงูŠุฏุฑูˆูƒูˆุฑุชูŠุฒูˆู†

3- ุชุดุฎูŠุต cushing
ู†ู†ุทูŠ ุฏูŠูƒุณุงู…ูŠุซุงุฒูˆู†

4-ุนู„ุงุฌ ุจุฏูŠู„ ุจุญุงู„ุฉ CAH
ู†ู†ุทูŠ ุฌุฑุนู‡ ุนุงู„ูŠุฉ ู…ู† ุงู„ูƒูˆุฑุชูŠุฒูˆู†ุงุช ุนู„ู…ูˆุฏ ุงู†ุฒู„ ACTH and CRH

5- antiinflammatory
6- ูŠุนุงู„ุฌ ุงู„ุญุณุงุณูŠู‡ ูˆ ุงู„ุฑุจูˆ
7- ุจุญุงู„ุฉ ุงู„ุทูู„ ุงุฐุง ุนุฏู‡ ู…ุดูƒู„ู‡ maturation ุจู„ุฑุฆู‡ ู†ู†ุทูŠ ุฏูŠูƒุณุงู…ูŠุซุงุฒูˆู† ุงูˆ ุจูŠุชุงู…ูŠุซุงุฒูˆู† ุจุดูƒู„ im ู„ู„ุงู… ู‚ุจู„ ูŠูˆู…ูŠู† ู…ู† ุงู„ุญุจุงู„ู‡

*** prednison ุงู…ู† ู„ู„ุญุงู…ู„
#adrenal
ุชุญุฏุซ ุนู…ู„ูŠุชูŠู† ุจ Bone

Osteoclasts and osteoblasts

Clasts
ูŠูƒุณุฑ ุงู„ุนุธู…
ูˆ ูŠุณู…ู‰ ุจ ุนู…ู„ูŠู‡ bone resorption


Blasts
ู‡ูˆ ุนู…ู„ูŠู‡ ุงู„ุจู†ุงุก
Bone building
ุชุตู†ูŠุน ุฎู„ุงูŠุง ุนุธู… ุฌุฏูŠุฏู‡
#bone ๐Ÿซ ๐Ÿ‘‡
ู…ุซู„ุง ูŠุณุฃู„ ุดู†ูˆ ุงู„ุนู…ู„ูŠู‡ ุงู„ูŠ ูŠุตูŠุฑ ุจูŠู‡ุง
Replace damage bone and maintain calcium homeostasis
ู‡ูŠ :ุงู„ remodeling ูƒู„ ุดูƒุฏ ูƒู„ ุณู†ู‡ ุจู†ุณุจุฉ 10%
ู…ุชู‰ ูŠุญุฏุซ bone loss

ุนู†ุฏู…ุง ูŠูƒูˆู† resorption
ุงุนู„ู‰ ู…ู† formation
ุฐูˆู„ูŠ ุงู„ุตูˆุฑ ูŠููŠุฏู† ู„ู„ุชุฐูƒุงุฑ ุงู†ูˆ
๐ŸฆดOsteoclast= break down bone (bone resorption) .

๐Ÿฆด Osteoblasts= bone building (synthesis new bone)

#bone
๐Ÿ”ฎOsteoporosis : is characterised by progressive loss of bone mass and skeletal fragility
ุชุชู…ูŠุฒ ุจุงู„ูู‚ุฏุงู† ุงู„ุชุฏุฑูŠุฌูŠ ู„ูƒุชู„ุฉ ุงู„ุนุธุงู… ูˆู‡ุดุงุดุฉ ุงู„ู‡ูŠูƒู„ ุงู„ุนุธู…ูŠ

๐Ÿ”ฎPaget disease : is a disorder of bone remodeling that results in disorganized bone formation and enlarged or misshapen bones
ู‡ูˆ ุงุถุทุฑุงุจ ููŠ ุฅุนุงุฏุฉ ุชุดูƒูŠู„ ุงู„ุนุธุงู… ูŠุคุฏูŠ ุฅู„ู‰ ุชูƒูˆูŠู† ุนุธุงู… ุบูŠุฑ ู…ู†ุชุธู…ุฉ ูˆุนุธุงู… ู…ุชุถุฎู…ุฉ ุฃูˆ ู…ุดูˆู‡ุฉ

๐Ÿ”ฎOsteomalacia : is softening of the bones that is most often attributed to vit D deficiency (in children referred to as rickets)
ุชู„ูŠูŠู† ุงู„ุนุธุงู… ุงู„ุฐูŠ ูŠุนุฒู‰ ููŠ ุฃุบู„ุจ ุงู„ุฃุญูŠุงู† ุฅู„ู‰ ู†ู‚ุต ููŠุชุงู…ูŠู† ุฏ (ูŠุดุงุฑ ุฅู„ูŠู‡ ุนู†ุฏ ุงู„ุฃุทูุงู„ ุจุงู„ูƒุณุงุญ)

๐Ÿ”ฎOsteoclasts : cells that break down bone, a process known as bone resorption
ุงู„ุฎู„ุงูŠุง ุงู„ุชูŠ ุชุญุทู… ุงู„ุนุธุงู…ุŒ ูˆู‡ูŠ ุนู…ู„ูŠุฉ ุชุนุฑู ุจุงุณู… ุงุฑุชุดุงู ุงู„ุนุธู…*(bone resorption ุชุนู†ูŠ ุงู„ุนู…ู„ูŠุฉ ุงู„ุชูŠ ูŠู‚ูˆู… ุงู„ุฌุณู… ู…ู† ุฎู„ุงู„ู‡ุง ุจุชูƒุณูŠุฑ ุฃูˆ ุชุญู„ูŠู„ ุงู„ุนุธุงู… ูˆุฅู…ุชุตุงุตู‡ุง)

๐Ÿ”ฎOsteoblasts : bone building cells synthesize new bone
ุชู‚ูˆู… ุฎู„ุงูŠุง ุจู†ุงุก ุงู„ุนุธุงู… ุจุชูƒูˆูŠู† ุนุธุงู… ุฌุฏูŠุฏุฉ

#bone
๐Ÿ”– ูƒู„ ุงู„ุงุฏูˆูŠุฉ ุงู„ู…ุฐูƒูˆุฑุฉ ุจู„ูƒุฌุฑ 4

โžก๏ธDrugs affecting bone metabolism


โžก๏ธCalcium supplement

๐Ÿ’ŠCalcium carbonate โžก๏ธ 40% elemental calcium
ูˆูŠุคุฎุฐ ู…ุน ุงู„ูˆุฌุจุฉ

๐Ÿ’ŠCalcium citrate โžก๏ธ 21% elemental calcium
ูˆู…ู…ูƒู† ู†ุงุฎุฐู‡ ู‚ุจู„ ุงูˆ ุจุนุฏ ุงู„ุงูƒู„

๐Ÿ’ŠVitamin D2 ( ergocalciferol )
๐Ÿ’ŠVitamin D3 ( Cholecalciferol)


โžก๏ธBisphosphonate

๐Ÿ’ŠAlendronate
๐Ÿ’ŠRisedronate
๐Ÿ’ŠZoledronic acid
๐Ÿ’ŠEtidronate
๐Ÿ’ŠIbandronate
๐Ÿ’ŠPamidronate
๐Ÿ’ŠTiludronate


โžก๏ธMonoclonal antibody

๐Ÿ’ŠDenosumab


โžก๏ธParathyroid agents

๐Ÿ’ŠTeriparatide โžก๏ธ recombinant parathyroid hormone

๐Ÿ’ŠAbaloparatide โžก๏ธanalog of parathyroid hormone related peptide


โžก๏ธSelective estrogen receptor modulators

๐Ÿ’ŠRaloxifen


โžก๏ธCalcitonin



#bone
๐Ÿ”–ู‡ุณุฉ ู†ุฑุงุฌุน ุดูˆูŠุฉ ุชูุงุตูŠู„ ู…ู‡ู…ุฉ ูŠู„ุง ุฌุงู‡ุฒูŠู† ู†ูƒู…ู„ ๐Ÿ‘€ ุŸุŸ

ูŠู„ุง ๐Ÿ“๐Ÿ“

*๏ธโƒฃBisphosphonate โžก๏ธ Preferred in postmenopausal osteoprosis

*๏ธโƒฃIbandronate , Zoledronic acid
ุงุซู†ูŠู†ู‡ู… ู†ูƒุฏุฑ ู†ุงุฎุฐู‡ู… IV ๐Ÿ’‰๐Ÿ’‰

*๏ธโƒฃZoledronic acid have the highest antiresorptive activity

*๏ธโƒฃ Etidronate have the lowest antiresorptive activity

*๏ธโƒฃ Drug holiday for 5๏ธโƒฃ years for oral bisphosphonate

But

๐Ÿšฉ years for zoledronic acid 

๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”

๐Ÿ‘‰First line agent for osteoporosis + pt at higher risk of fracture is

Denosumab

ุงูŠุถุง ู‡ูˆ ูŠุณุชุฎุฏู… ู„ู„๐Ÿ‘‡๐Ÿ‘‡
Postmenopausal osteoporosis in women at high risk of racture

๐Ÿ’กูˆุชุฐูƒุฑ ุงู† ุงู„ Denosumab ุชุฒูŠุฏ ูˆูŠุงู‡ ู†ุณุจุฉ ุญุฏูˆุซ
โžก๏ธInfection
โžก๏ธDeramtologic reactions
โžก๏ธHypOcalcemia
โžก๏ธRarely osteonecrosis of the jaw
โžก๏ธAtypical fractures

๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”
Parathyroid agents
ุดู†ูˆ ุงุฏูˆูŠุชู‡ู… ุŸ
โžก๏ธTeriparatide
โžก๏ธAbaloparatide

ุงุซู†ูŠู†ู‡ู… ูŠุดุชุบู„ูˆู† ูƒ
Agonist at parathyroid hormone receptor

ู†ู†ุทูŠู‡ู… ู…ุฑุฉ ูˆุญุฏุฉ ูŠูˆู…ูŠุง ูˆุจุดูƒู„ subc

ุดู†ูˆ ุงู„ู…ูŠูƒุงู†ุฒู… ู…ุงู„ุชู‡ู… ุŸ
โžก๏ธStimulation of osteoclast
โžก๏ธIncreased bone formation and bone strength

๐Ÿ’ฌุฒูŠู† ุงู„ู…ู† ู†ู†ุทูŠู‡ู… ู‡ุฐู‡ ุงู„ุงุฏูˆูŠุฉ ุŸ
ูู‚ุท ู„ู„ู†ุงุณ ุงู„ู„ูŠ ุนุฏู‡ู… ู†ุณุจุฉ ุนุงู„ูŠุฉ ู„ู„ูƒุณูˆุฑ ุงูˆ ุงู„ู„ูŠ ูุดู„ ุงู„ุนู„ุงุฌ ูˆูŠุงู‡ู… ุจุงู„ุงุฏูˆูŠุฉ ุงู„ู„ูŠ ุฐูƒุฑู†ุงู‡ู… ู‚ุจู„ ุงูˆ ู…ุงูƒุฏุฑูˆุง ูŠุชุญู…ู„ูˆู† ุงู„ุงุฏูˆูŠุฉ ุงู„ุจุงู‚ูŠุฉ ูู†ูƒุฏุฑ ู†ุณุชุฎุฏู… ู‡ุฐู‡ ุงู„ุงุฏูˆูŠุฉ โœ”๏ธโœ”๏ธ

๐Ÿ’ฌุฒูŠู† ุดู†ูˆ ุงู„ S.E ู…ุงู„ุชู‡ู… ุŸ
โš ๏ธHypercalcemia
โš ๏ธOrthostatic hypOtension
โš ๏ธIncreased risk of osteosarcoma in rats

#bone
โค1
Note s4 pinned ยซ#contraceptive #estrogen #bone #contraceptive #Antiinflammation #pituitary #Diabetes_ #cancer #DMARDs #adrenal #dm #ูุงุฑู…ุงยป
ุญุจุดูƒู„ุงุช ุงู„ูุงุฑู…ุง ๐Ÿงฎ

ูƒู„ ุฃุฏูˆูŠุฉ ุงู„ู…ู†ู‡ุฌ ุงู„ูŠ ุชู…ุชู„ูƒ ู‡ุฐู‡ ุงู„ุชุฃุซูŠุฑุงุช ู‡ูŠ ูู‚ุท

Hyperkalemia โ†’ spirolocatone , norgestimate , drospirenone

Hypokalemia โ†’ leflunomide, corticotropin, aldosterone, mineralocorticoid, abiraterone

๐Ÿ’Š๐Ÿ’Š๐Ÿ’Š

Hypercalcaemia โ†’ Teriparatide, Abaloparatide

Hypocalcemia โ†’ Denosumab

https://t.me/Quizpharmcy
#ูุงุฑู…ุง
โค1
โญ•๏ธุœ
ุฃุฏูˆูŠุฉ bisphosphonates ู„ุนู„ุงุฌ OP ูˆุฃู‡ู… ุงู„ู…ู„ุงุญุธุงุช ุนู„ูŠู‡ุง

"Alendronate"
if oral tab โฉ daily or weekly
if effervescent โฉ weekly

"Ibandronate"
if oral tab โฉ daily or monthly
if intravenous โฉ every 3 month

"Risedronate"
if oral tab โฉ daily,weekly, or monthly
if oral delayed-release tab โฉ weekly

"Zoledronic acid"
intravenous โฉ yearly

โšก๏ธ ูƒู„ู‡ู… ู„ุงุฒู… ุฃุฎุฐู‡ู… ูˆูŠ ู…ุงุก ุทุจูŠุนูŠ ู„ุง ุญู„ูŠุจ ูˆู„ุง ูƒู‡ูˆุฉ ูˆู„ุง ุนุตูŠุฑ ..
โบ๏ธู„ุงุฒู… ูŠูƒูˆู† ุงู„ู…ุงุก ุญูˆุงู„ูŠ ูฆ-ูจ ุงูˆู†ุต ูŠุนู†ูŠ ุจุญุฏูˆุฏ 180-240 ู…ู„
โบ๏ธูŠู†ูˆุฎุฐูˆู† ู‚ุจู„ ุงู„ุฃูƒู„ ูˆุงู„ุฃุฏูˆูŠุฉ ุจู†ุต ุณุงุนุฉ (ุนุฏุง Ibandronate ุจุณุงุนุฉ)
โบ๏ธูŠุญุชุงุฌ ุชูƒุนุฏ ุงูˆ ุชูˆูƒู ู…ุฏุฉ ู†ุต ุณุงุนุฉ ู„ูƒู„ ุงู„ุฃุฏูˆูŠุฉ(ุนุฏุง Ibandronate ูŠุญุชุงุฌ ุณุงุนุฉ)

โœจุฅุณุชุซู†ุงุก ุจุณูŠุท ูู‚ุท
Risedronate delayed release tab
๐Ÿ”ขูŠุญุชุงุฌ ุฃู‚ู„ ุดูŠ ูค ุงูˆู†ุต ู…ู† ุงู„ู…ุงุก ูŠุนู†ูŠ 120 ู…ู„ ุชู‚ุฑูŠุจุง
๐Ÿ”ขูˆูŠู†ูˆุฎุฐ ุจุนุฏ ูˆุฌุจุฉ ุงู„ูุทูˆุฑ ู…ุจุงุดุฑุฉ

1 ounce = 30ml


#ob
#๏ธโƒฃุฃู‡ู… ู…ุง ุจฺ†ุงุจุชุฑ 4๏ธโƒฃ ุชฺฏุฏุฑ ุชุนุชู…ุฏู‡ ูˆุชุนุชุจุฑู‡ ู…ุฑุงุฌุนุฉ ู„ู‚ุฑุงูŠุชูƒ ๐Ÿ’€๐Ÿ’€๐Ÿ’€๐Ÿ’€

ุจุงู„ุจุฏุงูŠุฉ ุฐุงูƒุฑ ุชุนุฑูŠูุงุช ู…ู…ูƒู† ูŠุฌู† ูู„ุงุฒู… ุชุนุฑูู‡ู†
Osteoporosis
ูŠุชู…ูŠุฒ ุงู†ูˆ ูƒุชู„ุฉ ุงู„ุนุธู… ุชู‚ู„ ูˆูŠูƒูˆู† ุงู„ู‡ูŠูƒู„ ุงู„ุนุธู…ูŠ ู‡ุด ุจุงู„ุชุงู„ูŠ ูŠูƒูˆู† ุนุฑุถุฉ ู„ู„ูƒุณุฑ ูˆูƒุฐู„ูƒ ู…ุฑุงุญ ุฃฺฏุฏุฑ ุงุชุญุฑูƒ
ูˆูŠุตูŠุฑ ุนู†ุฏ ุงู„ู†ุณุงุก ุจุนุฏ ุณู† ุงู„ูŠุฃุณ
ูˆุงู„ุฃุดุฎุงุต ุงู„ูƒุจุงุฑ ุจุงู„ุนู…ุฑ ุจูƒู„ุง ุงู„ุฌู†ุณูŠู†
๏ปฟ
Paget disease
ูŠุชู…ูŠุฒ ุงู†ูˆ ุงู„ุนุธู… ุฑุงุญ ูŠูƒูˆู† ุบูŠุฑ ู…ู†ุธู… ูˆู…ุชูˆุณุน ูˆุดูƒู„ู‡ ู…ุฎุฑุจุท
ูˆูŠุฎุชู„ู ุนู† OP ุงู†ูˆ ูŠุตูŠุจ ุนุธุงู… ู‚ู„ูŠู„ุฉ
ูˆูŠูƒูˆู† ุงู„ู…ุฑูŠุถ ูŠุนุงู†ูŠ ู…ู† ุฃู„ู… ูˆุชุดูˆู‡ุงุช ูˆูƒุณูˆุฑ
๏ปฟ
Osteomalacia
ู‡ูˆ ุชู„ูŠู† ุงู„ุนุธู… ูŠุนู†ูŠ ุงู„ุนุธู… ูŠุตูŠุฑ ู„ูŠู†
ูˆุณุจุจู‡ ู†ู‚ุต ููŠุชุงู…ูŠู† D
ูˆู‡ูˆ ู‡ุฐุง ู†ูุณู‡ ุงู„ู„ูŠ ูŠุตูŠุฑ ุนู†ุฏ ุงู„ุฃุทูุงู„ ูˆูŠุณู…ูˆู‡ ุงู„ูƒุณุงุญ rickets
๏ปฟ
prevention of OP
ุญุชู‰ ุฃู‚ู„ู„ ุงุญุชู…ุงู„ูŠุฉ ุฎุณุงุฑุฉ ุงู„ุนุธู… ุนู†ุฏ ุงู„ู†ุณุงุก ุจุนุฏ ุณู† ุงู„ูŠุฃุณ
๐Ÿ›‘ู„ุงุฒู… ุชุงูƒู„ ุจุงู„ูˆุฌุจุฉ ุชุญุชูˆูŠ vit. D,Ca ุจุดูƒู„ ูƒุงููŠ
๐Ÿ›‘ุชุณูˆูŠ ุชู…ุงุฑูŠู†
๐Ÿ›‘ุชูˆู‚ู ุชุฏุฎูŠู†
๐Ÿ›‘ุชู‚ู„ู„ ุงุณุชู‡ู„ุงูƒ ูƒุญูˆู„
ุงู„ุนู†ุฏู‡ ู†ู‚ุต ูƒุงู„ุณูŠูˆู… ู…ู…ูƒู† ูŠู†ุทูˆู‡:

๐Ÿ˜€Calcium carbonate
ูˆู‡ูˆ ุงู„ุดุงุฆุน ูˆู…ูˆ ุบุงู„ูŠ ูˆูŠุญุชูˆูŠ ุนู„ู‰
40% ca element
ูˆู„ุงุฒู… ูŠู†ูˆุฎุฐ ูˆูŠ ุงู„ุฃูƒู„ ุนู„ู…ูˆุฏ ุงู„ุฃู…ุชุตุงุต

๐Ÿ˜„calcium citrate
21% ca element
ูˆุนุงุฏูŠ ู‚ุจู„ ุงูˆ ุจุนุฏ ุงู„ุฃูƒู„
โš ๏ธู…ู…ู†ูˆุน ูŠู†ูˆุฎุฐ ุงู„ูƒุงู„ุณูŠูˆู… ูˆูŠ
iron , thyroid replacement, fluoroquinolone , Tetracycline

ุงู„ุนู†ุฏู‡ ู†ู‚ุต vit.D ูŠู†ุทูˆู‡:
ergocalciferol (D2)
cholecalciferol (D3)


Treatment of OP
ุฃูˆู„ ุนุงุฆู„ุฉ ูˆู‡ู…ุฉ
๐Ÿ’€bisphosphonates

Risedronate,Alendronate,Zoledronic acid
ู…ุฌู…ูˆุนูŠู† ุจูƒู…ุฉ ุฃุฑุฒ
preferred agent for treatment of postmenopausal osteoporosis

ู‡ุฐู† ุงู„ุฃุฏูˆูŠุฉ ูˆุจู‚ูŠุฉ ุงู„ุนุงุฆู„ุฉ ู…ุซู„ :
etidronate, Ibandronate, pamidroante, tiludronate
ุชุณุชุฎุฏู… ููŠ ุนู„ุงุฌ :
OP, Paget disease, bone metastasis, hypercalcemia of malignancy

๐Ÿ’กุœM.O.A : ุชุฑุชุจุท ุจู€ hydroxyapitate crystals ุงู„ู…ูˆุฌูˆุฏ ุจุงู„ุนุธุงู… ูˆุชู‚ู„ู„ ู…ู† osteoclast ุจุงู„ุชุงู„ูŠ ุชู‚ู„ู„ ู…ู† bone loss ูˆ fructure

โš ๏ธู…ู…ู†ูˆุน ุฃู†ุทูŠ ู„ู…ุฑุถู‰ ุงู„ูƒู„ู‰ ู„ุฃู† ู‡ูˆ ูŠู†ุทุฑุญ ุนู† ุทุฑูŠู‚ ุงู„ูƒู„ู‰
โœ”๏ธ ุงู„ู…ุง ูŠฺฏุฏุฑ ูŠุงุฎุฐ ุงู„ู€ oral ุฃู†ุทูŠ IV ุณูˆุงุก
Zoledronic acid , Ibandronate are alternative
๐Ÿ”˜ุฃู‡ู… A.E : ูŠุณูˆูŠ ู‡ูˆุงูŠ ู…ุดุงูƒู„ ุจุงู„ู…ุนุฏุฉ ู…ุซู„
esophagitis, esophageal ulcer
ูˆุญุชู‰ ุฃุญู„ู‡ุง ุงูˆ ุงู‚ู„ู„ู‡ุง ุงู†ุตุญ ุงู„ู…ุฑูŠุถ ูŠุจู‚ู‰ ูˆุงูƒู ู…ู† ูŠุงุฎุฐ ู‡ุงูŠ ุงู„ุฃุฏูˆูŠุฉ

โค๏ธ ู†ู†ุตุญ ุงู„ู…ุฑูŠุถ ุจุฃุฎุฐ ุฑุงุญุฉ ู…ู† ุงู„ุฃุฏูˆูŠุฉ durg holiday ูˆุฎุงุตุฉ
ุจุนุฏ ูฅ ุณู†ูŠู† ู…ู† ุงุณุชุฎุฏุงู… ุงู„ู€ oral
ุงูˆ ูฃ ุณู†ูŠู† ู…ู† ุงุณุชุฎุฏุงู… Zoledronic
ู„ุฃู† ุงู„ุฃุณุชุฎุฏุงู… ุงู„ู…ุทูˆู„ ู…ู…ูƒู† ูŠุณูˆูŠู„ูŠ ุชู†ุฎุฑ ุจุงู„ููƒ ุงูˆ ูƒุณุฑ ุจุงู„ุญูˆุถ ูˆู‡ุฐู† ู†ุงุฏุฑุงุช ุจุณ ู…ู…ูƒู† ูŠุตูŠุฑู†

๐Ÿ’€Denosumab
๐Ÿ’กุœM.O.A : ูŠุฑุชุจุท ุจุฑุณุชุจุฑ ุฅุณู…ู‡ ุฑุงู†ูƒู„ RANKL
receptor activator of nuclear factor kappa-b ligand
ูˆูŠุซุจุท osteoclast ุชูƒูˆู†ู‘ู‹ุง ูˆูˆุธูŠูุฉู‹
โœ”๏ธู…ูุถู„ ู„ู„ู€
postmenopausal Osteoporosis in women at high risk of fracture
๐Ÿ”˜ูŠุนุทู‰ SC ูƒู„ ูฆ ุฃุดู‡ุฑ
โœ… ูŠุนุชุจุฑ first line ู…ุซู„ ู…ฺฏู„ู†ุง ุจุนู„ุงุฌ PM-OP with high risk of fracture
๐Ÿ”˜ุฃู‡ู… A.E : ุœhypocalcemia
๏ปฟ
๐Ÿ’€Parathyroid agents
ุฏูˆุงุฆูŠู†
Teriparatide like PTH
Abaloparatide like PTHrP

๐Ÿ’กุœM.O.A: ู‡ุงูŠ ุงู„ุฃุฏูˆูŠุฉ ุชุฎุชู„ู ุนู† ุงู„ุจู‚ูŠุฉ
ู‡ูˆ ุงู†ูˆ ุชุดุชุบู„ ุนู„ู‰ ุชูƒูˆู† ุงู„ุนุธุงู… bone formation ุจุงู„ุชุงู„ูŠ ุชุญูุฒ osteoblast ูˆุชุฒูŠุฏ bone strength
๐Ÿ”˜ุฃู‡ู… A.E : ุœhypercalcemia, orthoststic hypotension
ูˆูƒุฐู„ูƒ osteosarcoma in rats๐Ÿฆซ

โœ”๏ธู„ุง ูŠู†ุตุญ ุจุงู„ุฃุณุชุฎุฏุงู… ู„ุฃูƒุซุฑ ู…ู† ุณู†ุชูŠู†

๐Ÿ’€Selective estrogen receptor modulator
ุงู„ุฃุณุชุฑูˆุฌูŠู† ูŠู„ุนุจ ุฏูˆุฑ ู…ู‡ู… ุจู€ ุชุซุจูŠุท osteoclast ูˆุชู†ุดูŠุท osteoblast ูู‚ู„ุฉ ู‡ุฐุง ุงู„ู‡ุฑู…ูˆู† ุนู†ุฏ ุงู„ู†ุณุงุก ูˆุฎุงุตุฉ Postmenopausal ูŠุคุฏูŠ ุงู„ู‰ ุฒูŠุงุฏุฉ osteoclast ูˆู…ู…ูƒู† ูŠุคุฏูŠ ุงู„ู‰ bone loss ุงุฐุง ู…ุง ุชุนุงู„ุฌุช

โบ๏ธู…ู…ูƒู† ุฃู†ุทูŠ estrogen supplements ุจุณ ู…ุง ุจูŠ ููˆุงุฆุฏ ู„ุฃู† ูŠุดุชุบู„ ุนู„ู‰ ูƒู„ ุงู„ุฑุณุจุชุฑุงุช ุงู„ู…ูˆุฌูˆุฏุฉ ุจุงู„ุฌุณู… ููŠุญูุฒ ุฑุณุจุชุฑุงุช bone,breast,uterus
ูู…ู…ูƒู† ูŠุณูˆูŠู„ูŠ ูƒุงู†ุณุฑ ู„ุฐู„ูƒ ุบูŠุฑ ู…ูุถู„
โœ”๏ธRaloxifene
ู‡ูˆ SERM
๐Ÿ’กุœM.O.A : ูŠุดุชุบู„ agonist ุนู„ู‰ ุงู„ุนุธู…
ูˆ antagonist ุนู„ู‰ breast, uterus
ุจุงู„ุชุงู„ูŠ ู…ุง ูŠุณูˆูŠู„ูŠ ูƒุงู†ุณุฑ
โบ๏ธูŠุนุชุจุฑ ุจุฏูŠู„ ููŠ ุญุงู„ุฉ ูุดู„ ุจู‚ูŠุฉ ุงู„ุฃุฏูˆูŠุฉ ู…ุซู„ bis ุงูˆ deno
๐Ÿ”˜ุฃู‡ู… A.E :ุœ hot flash, leg cramp , venous thromboembolism
๏ปฟ
๐Ÿ’€ Calcitonin
โบ๏ธุœ ูŠุนุงู„ุฌ OP ู„ู„ู†ุณุงุก ุงู„ู„ูŠ ุตุงุฑู„ู‡ุง ุฃู‚ู„ ุดูŠ ูฅ ุณู†ูˆุงุช ู…ู† ูˆุตู„ุช Postmenopausal
โบ๏ธุœ ูŠู‚ู„ู„ bone resorption
โบ๏ธ ุœุฃู‚ู„ ูุนุงู„ูŠุฉ ู…ู† ุจู‚ูŠุฉ ุงู„ุฃุฏูˆูŠุฉ
โบ๏ธ ุœุบูŠุฑ ู…ูˆุตู‰ ุจู‡ ู„ูุชุฑุฉ ุทูˆูŠู„ุฉ
๐Ÿ”˜ุœ ูŠูˆุฎุฐ intranasal ุจุฎุงุฎ ุจุงู„ุฃู†ู
๐Ÿ”˜ุœ ุฃู‡ู… A.E : ุœrhinitis ูˆ nasal symptoms
ุงูƒูŠุฏ ู„ุฃู† ุขู†ู‡ ุฌุงูŠ ุฃุฎุฐู‡ ุนู† ุทุฑูŠู‚ ุงู„ุฃู†ู
๏ปฟ
๐Ÿ”ฅุฅุฐุง ุฃุฌุงูƒ ูƒูŠุณ ุนู† OP ูˆุฑุงุฏ 1st line ฺฏุจู„ ููƒุฑ ุจุงู„ู€ bis
ุจุณ ุฅุฐุง ฺ†ุงู† ุนู†ุฏู‡ ูƒุณุฑ ุฃูˆ ู‡ุณุชุฑูŠ ูƒุณูˆุฑ ููƒุฑ ุจู€ Denosumab ุงูˆ Parathyroid agents


#ob
๐Ÿ‘1
ูŠุฌูŠูƒ ุณุคุงู„ ูŠุงุนู„ุงุฌ ูŠุฒูŠุฏ ุงูˆ ูŠู†ู‚ุต ุงู„ูˆุฒู† ุงูˆ ู…ุญุงูŠุฏ ุŸ!

ุณู‡ู„ู‡ ุงุญูุธูˆ ู‡ุฐู† :

*ุงู„ูŠ ูŠุฒูŠุฏู† ุงู„ูˆุฒู† weight gain :
1-ุงู„ู€ insulin
2-ุงู„ู€ Sulfonylureas ู„ุงู† ุชุฎู„ูŠ B-cell ุชูุฑุฒ ุงู†ุณูˆู„ูŠู†
3- ุงู„ู€ Glinides ู„ุงู† ุชุฎู„ูŠ B-cell ุชูุฑุฒ ุงู†ุณูˆู„ูŠู†
4- ุงู„ู€ Thiazolidinediones (TZD ) ุจุณุจุจ ุญุจุณ ุงู„ู…ุงุก

*ุงู„ูŠ ูŠู†ู‚ุตู† ุงู„ูˆุฒู† weight loss :
1-ุงู„ู€ Metformin ุจู…ู‚ุงุฏุฑ 2-3 ูƒูŠู„ูˆ
2-ุงู„ู€ GLP ุจู…ู‚ุงุฏุฑ 1-3 ูƒูŠู„ูˆ

*ุงู„ู…ุญุงูŠุฏุฉ ู„ู„ูˆุฒู† weight neutra :
ุงู„ู€ DPP-4 inhibitors

ุจุงู‚ูŠ ุงู„ุนู„ุงุฌุงุช ู…ุง ู…ุฐูƒูˆุฑ ุดูŠุณูˆู†.
#dm ๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡
ุจุนุฏ ุดุบู„ู‡ ู…ู‡ู…ุฉ ูŠูƒู„ูƒ ูŠุงุนู„ุงุฌุงุช ู…ุง ู†ู†ุทูŠู‡ู† ุณูˆู‡ ุŸุŸ
ุณู‡ู„ุงุช ู‡ู† ุงู„ูŠ ูŠุดุชุบู„ ุจู†ูุณ ุงู„ู…ูŠูƒุงู†ุฒู… ูˆู‡ู† :
1- ุงู„ู€ Sulfonylureas ู…ุง ูŠู†ุทูŠ ูˆูŠ ุงู„ู€ Glinides ู„ุงู† ู†ูุณ ุงู„ู…ูŠูƒุงู†ุฑู… ูˆูŠุณูˆู† ู‡ุจูˆุท ุจุงู„ุณูƒุฑ ุฎุทูŠุฑ

2- ุงู„ู€ DPP-4 inhibitors ู…ุง ูŠู†ุทูŠ ูˆูŠ GLP ุงู„ุณุจุจ ู„ุงู† ู†ูุณ ู…ูŠูƒุงู†ุฒู… ูˆูŠุณูˆู† ุณู…ูŠุฉ
ุดุบู„ู‡ ู…ู‡ู…ู‡ ุจุฎุตูˆุต ุนู„ุงุฌุงุช
ูู„ูˆุฒูŠู† ุณุฌู„ุช 2 ูˆุตุงุฑ ุงู„ุชู‡ุงุจ SGLT2

ู‡ุฐู† ุงู„ุนู„ุงุฌุงุช ู†ุณุชุฎุฏู…ู‡ู† ุจุญุฐุฑ ูˆูŠ ุงู„ู…ุฑุถู‰ ุงู„ูŠ ู…ุนุฑุถูŠู† ู„ู„ุญู…ุถู‡ ุงู„ูƒูŠุชูˆู†ูŠุฉ

SGLT2 should be used with caution in patients with risk for ketoacidosis